Drug Discovery Today: BIOSILICO
Information technology for drug discovery
| |
Additional Information
Readers
Authors
Librarians
Editors
Reviewers
Advertisers/Sponsors
ISSN: 1741-8364
Imprint: TRENDS
Drug Discovery Today: BIOSILICO has established itself as one of the leaders in the provision of news, reviews and analysis of
the issues and developments in computational drug discovery, associated with the same high quality and level of accessibility as its
sister publication Drug Discovery ... click here for full Aims & Scope
Drug Discovery Today: BIOSILICO has established itself as one of the leaders in the provision of news, reviews and analysis of
the issues and developments in computational drug discovery, associated with the same high quality and level of accessibility as its
sister publication Drug Discovery Today. Coverage includes systems biology, knowledge management and integration, bio/cheminformatics,
virtual screening, in silico modeling, e-clinical trials and text mining, among others. The articles are written by those actively
engaged in the IT/Pharma/Biotech sector and presented in the form of peer-reviewed reviews, comments and analysis articles.
Audience
The readership of Drug Discovery Today: BIOSILICO are the decision makers, the technically focused CEOs, big pharma R&D
heads and ITor Life Science strategists, as well as all levels of managers and lab heads, plus individual researchers within the pharma/biotech/IT
sector - anyone who has to keep abreast of the developments in computational drug discovery.
Drug Discovery Today: BIOSILICO
is distributed free of charge to registered readers who match our circulation profile.
Hide Aims & Scope
Editor
C. Watson
This is a spacer...
Home | Elsevier Sites | Privacy Policy | Terms and Conditions | Feedback | Site Map | A Reed Elsevier Company